Early Life and Education
Albert Chon completed a Master of Science in Computer Science with a focus on Systems at Stanford University. He also attained a Bachelor of Science in Computer Science with a specialization in Artificial Intelligence from the same institution. 
In high school, Albert took additional courses at Cerritos College and participated in the Summer Academy in Applied Science & Technology at the University of Pennsylvania, where he studied biotechnology. Albert achieved the distinction of being the valedictorian of his graduating class at Gretchen Whitney High School. 
Albert Chon started his career as an Analytical Chemist and Marketing Associate at Advanced Botanical Consulting & Testing Inc. in 2014. Afterward, he moved to the role of a Marketing Copywriter & Technical Analyst at L3 Networks. He served as a Researcher at Stanford Parallel Distributed Processing Lab in 2016. 
In 2017, Chen became a Full Stack Software Engineer at Linc Global Inc. In 2018, he contributed as a consultant at Open Zeppelin and served as a Software Development Engineer at Amazon. In 2021, Chen became a Tendermint Fellow.
Albert Chon joined Injective Protocol as a Co-founder and Chief Technology Officer (CTO) in 2018 alongside Eric Chen. Injective Protocol is a layer-2 DEX (Decentralized Exchange) that supports advanced trading features such as margin trading and derivatives. 
In April 2021, Injective raised $10 million in a funding round with participation from billionaire entrepreneur Mark Cuban, Pantera Capital, BlockTower Capital, Hashed Ventures, CMS Holdings, and QCP Capital. 
In August 2022, Injective raised $40 million to accelerate the adoption and growth of Web3 finance. The funding round consisted of Jump Crypto and BH Digital (the crypto arm of famed hedge fund manager Alan Howard). 
Albert Chon in an interview describes Injective Protocol:
"A platform that is building a fully decentralized derivatives and spot exchange protocol. This protocol is being developed on top of the Cosmos SDK."
Did you find this article interesting?